Mike Kratky
Stock Analyst at Leerink Partners
(2.93)
# 1,397
Out of 5,245 analysts
42
Total ratings
32%
Success rate
17.08%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Outperform | $622 → $573 | $438.10 | +30.79% | 2 | Apr 22, 2026 | |
| BBNX Beta Bionics | Maintains: Outperform | $25 → $24 | $11.82 | +103.05% | 2 | Apr 22, 2026 | |
| ZBH Zimmer Biomet Holdings | Initiates: Market Perform | $101 | $85.50 | +18.13% | 1 | Apr 13, 2026 | |
| SYK Stryker | Initiates: Outperform | $410 | $316.48 | +29.55% | 1 | Apr 13, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Outperform | $55 → $30 | $29.00 | +3.45% | 2 | Feb 26, 2026 | |
| PODD Insulet | Maintains: Outperform | $386 → $360 | $154.87 | +132.45% | 2 | Feb 19, 2026 | |
| TXG 10x Genomics | Maintains: Market Perform | $22 → $20 | $23.68 | -15.54% | 5 | Jan 27, 2026 | |
| PEN Penumbra | Downgrades: Market Perform | $374 | $328.69 | +13.79% | 2 | Jan 16, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $127 → $128 | $57.78 | +121.53% | 2 | Oct 1, 2025 | |
| INSP Inspire Medical Systems | Maintains: Market Perform | $116 → $97 | $43.84 | +121.26% | 7 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $110 | $78.60 | +39.95% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $87 | $72.10 | +20.67% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $45 | $14.97 | +200.70% | 2 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $16.92 | +30.02% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $42 | $34.73 | +20.93% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $75 | $85.78 | -12.57% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $9 | $40.90 | -78.00% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $45 | $1.21 | +3,619.01% | 2 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $145 → $315 | $517.26 | -39.10% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $26 → $31 | $78.89 | -60.70% | 2 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $34.15 | -59.00% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $17.24 | +132.02% | 1 | Aug 15, 2022 |
Intuitive Surgical
Apr 22, 2026
Maintains: Outperform
Price Target: $622 → $573
Current: $438.10
Upside: +30.79%
Beta Bionics
Apr 22, 2026
Maintains: Outperform
Price Target: $25 → $24
Current: $11.82
Upside: +103.05%
Zimmer Biomet Holdings
Apr 13, 2026
Initiates: Market Perform
Price Target: $101
Current: $85.50
Upside: +18.13%
Stryker
Apr 13, 2026
Initiates: Outperform
Price Target: $410
Current: $316.48
Upside: +29.55%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Outperform
Price Target: $55 → $30
Current: $29.00
Upside: +3.45%
Insulet
Feb 19, 2026
Maintains: Outperform
Price Target: $386 → $360
Current: $154.87
Upside: +132.45%
10x Genomics
Jan 27, 2026
Maintains: Market Perform
Price Target: $22 → $20
Current: $23.68
Upside: -15.54%
Penumbra
Jan 16, 2026
Downgrades: Market Perform
Price Target: $374
Current: $328.69
Upside: +13.79%
Boston Scientific
Oct 1, 2025
Maintains: Outperform
Price Target: $127 → $128
Current: $57.78
Upside: +121.53%
Inspire Medical Systems
Aug 15, 2025
Maintains: Market Perform
Price Target: $116 → $97
Current: $43.84
Upside: +121.26%
Jun 16, 2025
Initiates: Outperform
Price Target: $110
Current: $78.60
Upside: +39.95%
Oct 25, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $72.10
Upside: +20.67%
Apr 25, 2024
Upgrades: Outperform
Price Target: $34 → $45
Current: $14.97
Upside: +200.70%
Jan 30, 2024
Initiates: Outperform
Price Target: $22
Current: $16.92
Upside: +30.02%
Oct 16, 2023
Initiates: Outperform
Price Target: $42
Current: $34.73
Upside: +20.93%
Oct 16, 2023
Initiates: Market Perform
Price Target: $75
Current: $85.78
Upside: -12.57%
Oct 16, 2023
Initiates: Outperform
Price Target: $9
Current: $40.90
Upside: -78.00%
Jan 24, 2023
Maintains: Outperform
Price Target: $33 → $45
Current: $1.21
Upside: +3,619.01%
Dec 20, 2022
Maintains: Outperform
Price Target: $145 → $315
Current: $517.26
Upside: -39.10%
Dec 15, 2022
Maintains: Market Perform
Price Target: $26 → $31
Current: $78.89
Upside: -60.70%
Nov 4, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $34.15
Upside: -59.00%
Aug 15, 2022
Maintains: Outperform
Price Target: $32 → $40
Current: $17.24
Upside: +132.02%